Triple negative breast cancer treatment options and limitations: future outlook

O Obidiro, G Battogtokh, EO Akala - Pharmaceutics, 2023‏ - mdpi.com
Triple negative breast cancer (TNBC) has a negative expression of estrogen receptors (ER),
progesterone receptors (PR), and human epidermal growth factor receptors (HER2). The …

A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer

V Jain, H Kumar, HV Anod, P Chand, NV Gupta… - Journal of Controlled …, 2020‏ - Elsevier
Breast cancer (BC) is one of the most prevalent cancers in women. Triple-negative breast
cancer (TNBC) in which the three major receptors ie estrogen receptor (ER), progesterone …

Progress in surface-modified silicas for Cr (VI) adsorption: A review

AK Mallik, MA Moktadir, MA Rahman… - Journal of Hazardous …, 2022‏ - Elsevier
Various toxic chemicals are discharging to the environment due to rapid industrialization
and polluting soil, water, and air causing numerous diseases including life-threatening …

Stimuli-responsive nanomedicines for overcoming cancer multidrug resistance

L Zhou, H Wang, Y Li - Theranostics, 2018‏ - pmc.ncbi.nlm.nih.gov
Chemotherapy is still a main option for cancer therapy, but its efficacy is often unsatisfying
due to multidrug resistance (MDR). The tumor microenvironment is considered a dominant …

Nanomaterials for cancer precision medicine

Y Wang, S Sun, Z Zhang, D Shi - Advanced materials, 2018‏ - Wiley Online Library
Medical science has recently advanced to the point where diagnosis and therapeutics can
be carried out with high precision, even at the molecular level. A new field of “precision …

[HTML][HTML] Mesoporous silica nanoparticles as carriers for therapeutic biomolecules

RR Castillo, D Lozano, M Vallet-Regí - Pharmaceutics, 2020‏ - mdpi.com
The enormous versatility of mesoporous silica nanoparticles permits the creation of a large
number of nanotherapeutic systems for the treatment of cancer and many other pathologies …

Targeted and redox-responsive drug delivery systems based on carbonic anhydrase IX-decorated mesoporous silica nanoparticles for cancer therapy

M Chen, J Hu, L Wang, Y Li, C Zhu, C Chen, M Shi… - Scientific reports, 2020‏ - nature.com
In this work, we developed a new antibody-targeted and redox-responsive drug delivery
system “MSNs-CAIX” by binding the anti-carbonic anhydrase IX antibody (A-CAIX Ab) on the …

Engineering functional inorganic–organic hybrid systems: advances in siRNA therapeutics

J Shen, W Zhang, R Qi, ZW Mao, H Shen - Chemical Society Reviews, 2018‏ - pubs.rsc.org
Cancer treatment still faces a lot of obstacles such as tumor heterogeneity, drug resistance
and systemic toxicities. Beyond the traditional treatment modalities, exploitation of RNA …

Recent advances of dendrimers as multifunctional nano-carriers to combat breast cancer

SK Dubey, M Kali, S Hejmady, RN Saha… - European Journal of …, 2021‏ - Elsevier
Breast Cancer (BC) is a highly heterogeneous malignant carcinoma that is the most
frequently occurring cancer in women. The major types of BC are luminal A, basal-like …

[HTML][HTML] Mesoporous silica platforms with potential applications in release and adsorption of active agents

C Chircov, A Spoială, C Păun, L Crăciun, D Ficai… - Molecules, 2020‏ - mdpi.com
In recent years, researchers focused their attention on mesoporous silica nanoparticles
(MSNs) owing to the considerable advancements of the characterization methods …